1. Role of STAT3 in Genesis and Progression of Human Malignant Gliomas
    Zangbéwendé Guy Ouédraogo et al, 2017, Molecular Neurobiology CrossRef
  2. Molecular Dynamic Simulation Study on Chromones and Flavonoids for the In Silico Designing of a Potential Ligand Inhibiting mTOR Pathway in Breast Cancer
    VarRuchi Sharma et al, 2020, Current Pharmacology Reports CrossRef
  3. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
    Amir Barzegar Behrooz et al, 2022, International Journal of Molecular Sciences CrossRef
  4. mTOR pathway inhibition alters proliferation as well as differentiation of neural stem cells
    Nataliya Romanyuk et al, 2024, Frontiers in Cellular Neuroscience CrossRef
  5. Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network
    Milad Ghomlaghi et al, 2021, International Journal of Molecular Sciences CrossRef
  6. Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule
    Cholpon S. Djuzenova et al, 2016, Oncotarget CrossRef
  7. Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
    Preeti Vyas et al, 2021, Frontiers in Immunology CrossRef
  8. Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer
    Ryan W. Holloway et al, 2021, Cancers CrossRef
  9. Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
    Yinan Shi et al, 2021, Frontiers in Pharmacology CrossRef